
CAS 2168561-20-2
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Nurulimab
CAS:Nurulimab (BCD-145) is an anti-CTLA-4 antibody with anti-cancer activity for the study of skin and musculoskeletal diseases.Purity:95.5% (SDS-PAGE); 97.3% (SEC-HPLC) - 95.5% (SDS-PAGE); 97.3% (SEC-HPLC)Color and Shape:LiquidNurulimab
CAS:Monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA4); elimination of cancer cells


